Literature DB >> 16920318

Determination of azelnidipine in human plasma by liquid chromatography-electrospray ionization-mass spectrometry.

Li Ding1, Li Li, Pengcheng Ma.   

Abstract

A liquid chromatography-electrospray ionization-mass spectrometry (LC-ESI-MS) method for the determination of azelnidipine in human plasma was established. Nicardipine was used as the internal standard (IS). After adjustment to a basic pH with sodium hydroxide solution (0.1 M), plasma samples were extracted with cyclohexane-diethyl ether (1:1, v/v) and separated on a C(18) column with a mobile phase of 20 mM ammonium acetate solution-methanol-formic acid (25:75:0.5, v/v). The electrospray ionization was employed in a single quadrupole mass spectrometer for the determination. The method was linear over the concentration range of 0.05-40 ng/ml. The lower limit of quantification (LLOQ) was 0.05 ng/ml. The intra- and inter-run standard deviations were less than 9.5% and 11.0%, respectively. The method was successfully applied to study the pharmacokinetics of azelnidipine in healthy Chinese volunteers.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16920318     DOI: 10.1016/j.jpba.2006.07.011

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  1 in total

1.  Validated Stability-Indicating RP-HPLC Method for the Simultaneous Determination of Azelnidipine and Olmesartan in Their Combined Dosage Form.

Authors:  Jayvadan K Patel; Nilam K Patel
Journal:  Sci Pharm       Date:  2014-02-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.